Skip to content
white-logo
  • Nfinity™ Platform
    • Nplify™
    • Ntensify™
    • Ncapsulate™
  • About
    • Our Team
    • Our History
    • Our Expertise
    • Partners
  • Library
  • Events
  • Careers
  • Contact Us
  • Nfinity™ Platform
    • Nplify™
    • Ntensify™
    • Ncapsulate™
  • About
    • Our Team
    • Our History
    • Our Expertise
    • Partners
  • Library
  • Events
  • Careers
  • Contact Us

All

A New Paradigm in mRNA Bioprocessing. How Ntensify™ Reshapes Affordability and Reduces Time-to-Market

Rabies mRNA Vaccine Download the case study as a pdf: Contact Us

Read More

Quantoom Biosciences Prepares for the Implementation of the Ntensify™ Midi System by Afrigen Biologics’ in their GMP Facility, Paving the Way for African-Owned mRNA Vaccine Production

New agreement paves way for development of first African-owned COVID-19 vaccine.

Read More

Quantoom Biosciences Collaborates with Stevanato Group to Elevate mRNA production with Nfinity™ Platform

New agreement paves way for development of first African-owned COVID-19 vaccine.

Read More

mRNA Production Reinvented

mRNA Production Reinvented Download the Corporate presentation as a pdf: Contact Us

Read More

Quantoom Biosciences expands its offerings with Nplify, a high-quality linear DNA service for mRNA synthesis

New agreement paves way for development of first African-owned COVID-19 vaccine.

Read More

Quantoom expands U.S. Market Reach with Key Appointments

New agreement paves way for development of first African-owned COVID-19 vaccine.

Read More

Quantoom Biosciences installs the first Ntensify™ system for mRNA manufacturing at Afrigen Biologics in Cape Town

New agreement paves way for development of first African-owned COVID-19 vaccine.

Read More

ImmuneWatch, Quantoom Biosciences and UAntwerp join forces to explore new in vitro and in silico assays that predict T cell responses in vaccines

New agreement paves way for development of first African-owned COVID-19 vaccine.

Read More

Quantoom Biosciences is growing in France with brand-new facilities for its DNA and enzymes activity located in Evry

New agreement paves way for development of first African-owned COVID-19 vaccine.

Read More

Rabies mRNA Vaccine

Rabies mRNA Vaccine Download the case study as a pdf: Contact Us

Read More
Older Posts »
white-logo-icon

At Quantoom Biosciences, we are bringing radical innovation to the way mRNA is produced in any research lab, biotech, biopharma or CDMO. We support our partners early on with sequence design & candidate screening up to (pre-)clinical development toward a successful mRNA product.

Navigation

Home

Products

About

Resources

Careers

Contact Us

 

Follow us on social media

Links

Cookies Notice

Privacy Policy

Subscribe to receive our latest news

© Copyright 2023 Quantoom Biosciences - All rights reserved. Website design and development by Holly Small Design